ISRCTN32435732已完成未知
Qualification of predictive biomarkers for epidermal growth factor receptor tyrosine kinase inhibitor therapy in oesophagogastric adenocarcinoma
niversity of Aberdeen (UK)0 个研究点目标入组 300 人开始时间: 2012年3月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients with oesophagogastric cancer must be eligible for and enrolled in the COG trial
- •2. Ability to provide written informed consent
- •3. Formalin-fixed and paraffin-embedded (FFPE) tumour material available
- •4. Male and female participants
- •5. Lower Age Limit 18 years
排除标准
- •1. Patients not enrolled in COG trial
- •2. Inability to provide written informed consent
- •3. No FFPE tumour material available for analysis
研究者
相似试验
进行中（未招募）
不适用
AMBITIOUSAtopic Dermatitis Biomarker Identification Trial in Omalizumab UsageSingle- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitis - AMBITIOUSAMBITIOUS is a trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitisAtopische Dermatitis is a common inflammatory skin disease showing chronically relapsing eczema and high association with elevated serum IgE levels.MedDRA version: 14.0Level: LLTClassification code 10029264Term: Neurodermatitis aggravatedSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-018559-84-DEMedizinische Fakultät der technischen Universität Muenchen20
进行中（未招募）
1 期
Skin bioMARkers for atopic eczema Therapy evaluatioatopic eczema (synonym atopic dermatitis) and the adverse treatment side effect epidermal atrophyMedDRA version: 21.1Level: LLTClassification code 10003641Term: Atopic eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 21.0Level: PTClassification code 10040799Term: Skin atrophySystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2019-002643-23-GBSheffield Teaching Hospitals NHS Foundation Trust37
进行中（未招募）
2 期
Skin biomarkers for atopic eczema therapy evaluation study 2ISRCTN52806782Sheffield Teaching Hospitals NHS Foundation Trust40
已完成
不适用
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismDementia With Lewy BodiesProgressive Supranuclear PalsyCorticobasal DegenerationParkinsonismParkinson DiseaseMultiple System AtrophyNCT04518059University Hospitals Cleveland Medical Center184
已完成
不适用
Elucidation of biomarkers to predict the presence of coronary vulnerable plaqueJPRN-UMIN000009806agasaki University Graduate School of Biomedical Sciences200